12.3202.14% ( -0.270 )
Trading: Nov 16, 10:27:05 (EDT)Overview
Aspen Neuroscience (ASPE)
Aspen Neuroscience, Inc. develops autologous induced pluripotent stem cell (iPSC)-derived cell replacement therapies for neurodegenerative diseases. The company...
- Open
- 12.450
- High
- 12.450
- Low
- 12.061
- Prev. Close
- 12.590
- Volume
- 18.07K
- Turnover
- 220.51K
- Avg Price
- 12.207
- Bid/Ask Ratio
- -28.21%
- Amplitude
- 3.09%
- 52wk High
- 14.900
- Volume Ratio
- 0.00
- Turnover Ratio
- 0.19%
- 52wk Low
- 11.200
- Float Mkt Cap
- 115.50M
- Market CapUSD
- 358.25M
- P/ETTM
- Loss
- P/EDynamic
- Loss
- P/EStatic
- --
- EPSTTM
- -2.30
- EPSDynamic
- -2.51
- EPSStatic
- --
- BVPS
- -8.63
- P/B
- --
- Circulating Supply
- 9.38M
- Dividend YieldTTM
- --
- DividendTTM
- --
- Shares
- 29.08M
- Min lot size
- 1
- Currency
- USD
News
Market Movers · Aspen Neuroscience tumbles 8% during regular trading
Market Movers · Aspen Neuroscience falls 9% during regular trading
TradingView · ARCH Venture Partners X Discloses 12.9% Stake in Aspen Neuroscience
PUBT · Aspen Neuroscience Awards Executive Chair Faheem Hasnain 321,672 Restricted Stock Units
TradingView · OrbiMed Advisors Discloses Investment at Aspen Neuroscience, Inc. with 12.3% Stake
Market Movers · Aspen Neuroscience tumbles 8% in post-IPO pullback
